BIOVIE INC. (BIVI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in USD.

Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Gross Profit Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Annual

-24M -16M -8M 0 8M 16M 24M 2025: -18.1M 2026: -22.7M 2025 2026

Net Income Annual

-24M -16M -8M 0 8M 16M 24M 2025: -17.5M 2026: -22.1M 2025 2026

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-21M -14M -7M 0 7M 14M 21M 2025: -19M 2026: -19M 2025 2026

Free Cash Flow Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Annual

0 2.5M 5M 7.5M 2025: 1.5M 2026: 7.2M 2025 2026

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-90.00 -60.00 -30.00 0.00 30.00 60.00 90.00 Q3 '24: -77.21 Q4 '24: -79.56 Q1 '25: -79.07 Q2 '25: -14.50 Q3 '25: -8.48 Q4 '25: -4.70 Q1 '26: -3.89 Q2 '26: -3.15 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.